| |
|
|
|
Redhill Biophrma ADR  
|
|
6.82 -0.11 (-0.02%) |
06-05 16:00 |
|
Open: |
6.93 |
Pre close: |
6.93 |
Target:
|
8.29 
|
|
High: |
7.01 |
Low: |
6.6 |
Resistance:
|
7.10
7.60
|
|
Volume: |
350,653 |
Market Cap: |
241M |
Support:
|
6.28
5.22
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.99
|
MACD |
MACD(12,26):
|
0.07 |
|
MA(20): |
7.05  |
Signal(12,26,9): |
0.13 |
|
MA(100): |
5.77 |
Stochastic Oscillator |
%K(14,3):
|
36.97 |
|
MA(250): |
6.39 |
%D(3): |
45.05 |
|
Average Volume(K) |
3-Month: |
47397
|
52-Week |
High:
|
9.12 |
|
10-Days: |
27482 |
Low: |
3.26 |
|
RSI |
RSI(14):
|
47.85 |
Change(%): |
-5.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.420 |
Return on Equity (ttm) |
-76.1 |
Shares Out. (M) |
35.27 |
|
EPS Est. Current Year |
-2.390 |
Return on Assets (ttm) |
-39.6 |
Shares Float (M) |
20.84 |
|
EPS Est. Next Year |
-0.540 |
PEG Ratio |
0.00 |
% Held by Insiders |
15.37 |
|
EPS Est. Next Quarter |
-0.620 |
Qtrly Rev. Growth |
17.0 |
% Held by Institutions |
20.91 |
|
Forward EPS |
1.700 |
Gross Profit (p.s.) |
0.114 |
Shares Short (K) |
1220 |
|
Book Value (p.s.) |
1.700 |
EBITDA (p.s.) |
-1.222 |
P/E |
-4.80 |
|
Sales Per Share |
0.178 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.01 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-40.75 |
P/S |
38.24 |
|
Operating Margin |
-686.71 |
Levered Free Cash Flow
(M) |
-25.55 |
P/CF |
-5.90 |
|
|
|
|
|
|
